
Federal bankruptcy judge approves Purdue Pharma and Sacklers' $6 billion opioid settlement
A US bankruptcy judge on Wednesday approved Purdue Pharma’s settlement plan that will see the Sacklers pay up to $6 billion to states and victims of addiction for their role in the opioid epidemic — which is a billion more than a previous settlement that was tossed out in December.
The Sackler family, who owns Purdue Pharma, will pay between $5.5 billion and $6 billion over 18 years, according to a recent statement from Connecticut Attorney General William Tong. And while the plan would put an end to civil claims against the family over Purdue’s involvement in the opioid epidemic, it does not release them from future criminal liability.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.